Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the ...
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce a ...
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") announces that further to its ...
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce a non ...
Treatment.com International (TSE:TRUE) has released an update. Restart Life Sciences Corp, a Canadian life sciences company, has successfully completed a debt settlement transaction, exchanging over 6 ...
Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (“Restart” or the “Company”) is pleased to announce that it ...
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback